VAXGEN INC
10-Q, EX-27.1, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: VAXGEN INC, 10-Q, 2000-08-14
Next: PEAPOD INC, 10-Q, 2000-08-14



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          18,033
<SECURITIES>                                    41,685
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                61,812
<PP&E>                                           3,083
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  65,064
<CURRENT-LIABILITIES>                            2,996
<BONDS>                                              0
                                0
                                          0
<COMMON>                                           136
<OTHER-SE>                                     109,710
<TOTAL-LIABILITY-AND-EQUITY>                    65,064
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                12,221
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   6
<INCOME-PRETAX>                               (10,186)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (10,186)
<EPS-BASIC>                                   (0.75)
<EPS-DILUTED>                                   (0.75)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission